Drug Shortage Report for MAXITROL

Last updated on 2023-01-25 History
Report ID 172560
Drug Identification Number 00042676
Brand name MAXITROL
Common or Proper name MAXITROL SUSPENSION
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) POLYMYXIN B SULFATE NEOMYCIN DEXAMETHASONE
Strength(s) 6000UNIT 3.5MG 0.1%
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-11-09
Actual start date
Estimated end date 2022-12-02
Actual end date 2023-01-13
Shortage status Resolved
Updated date 2023-01-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2023-01-25 French Compare
v4 2023-01-25 English Compare
v3 2022-11-10 English Compare
v2 2022-10-25 French Compare
v1 2022-10-25 English Compare

Showing 1 to 5 of 5